Eppin seems to be a promising target for developing immunocontraceptives for males. In an attempt to develop a safer vaccine, the immune response should be specifically directed according to its fertility inhibition mechanism. The mechanism of Eppin as an immunocontraceptive agent is now assumed to be the inhibitory effect of Eppin-specific antibody on sperm motility. Hence, to make Eppin a successful immunocontraceptive, avid and specific antibody responses have to be elicited. We had employed the inoculation modality of protein prime-peptide boost with rhEppin and epitope-based peptide, which has previously showed a satisfying result of fertility inhibition with minimal adverse effects. We here further explored the immunological features and efficiency of a protein prime-peptide boost strategy. The results of the present study showed that all the animals injected with rhEppin followed by epitope-based peptide boost, elicited enhanced specific anti-Eppin antibodies. The IgG subclasses of the antibodies generated by this regimen were primarily of IgG2b and IgG1 isotypes, and more importantly, the IgA level of epidydimis lavage was much higher, which correlated well with the results of cytokine profiles in spleen cell cultures. Furthermore, the results of peptide competition assays demonstrated that rhEppin alone prime-boost vaccination lead to a broader B-cell response while protein prime-epitope-peptide boosts directed the immune response mainly against the epitope. The results indicate that this immunization strategy may be advantageous in eliciting a highly specific humoral immune response.

Download full-text PDF

Source
http://dx.doi.org/10.4161/hv.7.8.16279DOI Listing

Publication Analysis

Top Keywords

protein prime-peptide
12
prime-peptide boost
12
immune response
12
highly specific
8
specific antibody
8
response protein
8
fertility inhibition
8
rheppin epitope-based
8
epitope-based peptide
8
response
5

Similar Publications

Objective: Novel vaccination approaches are required to control human immunodeficiency virus (HIV) infections. The membrane proximal external region (MPER) of Env gp41 subunit and the V3/glycans of Env gp120 subunit were known as potential antigenic targets for anti-HIV-1 vaccines. In this study, we prepared the modified dendritic cells (DCs) and mesenchymal stem cells (MSCs) with HIV-1 MPER-V3 gene using mechanical and chemical approaches.

View Article and Find Full Text PDF

Protection via a ROM4 DNA vaccine and peptide against Toxoplasma gondii in BALB/c mice.

BMC Infect Dis

January 2017

Department of Parasitology, Shandong University School of Medicine, Jinan, Shandong Province, 250012, People's Republic of China.

Background: Toxoplasma gondii (T. gondii) is an obligate intracellular protozoan parasite with a broad host range including most warm-blooded animals, including humans. T.

View Article and Find Full Text PDF

Development of an effective vaccine against HIV-1 infection is a main concern in worldwide. A potent vaccine for HIV-1 requires the induction and maintenance of both humoral and cellular immunity. In this study, the levels of humoral and cellular immune responses were compared using MPER-V3 injection in three immunization strategies such as DNA/DNA, peptide/peptide, and DNA/peptide (prime-boost).

View Article and Find Full Text PDF

Problem: In our previous study on adult male mice, we had identified one immunodominant epitope in hEppin and three epitopes in hFSHR that caused fertility inhibition. But it only demonstrated a moderate inhibitory effect on fertility, and the antifertility effect was unsatisfactory.

Method Of Study: Based on the protein prime-peptide boost inoculation modalities, we further investigated whether the antifertility capacity could be enhanced by a combined immunization with the two antigens.

View Article and Find Full Text PDF

The emergence of the pandemic H1N1 strain of influenza in 2009 was associated with a unique w-shaped age-related susceptibility curve, with higher incidence of morbidity and mortality among young persons and lower incidence among older persons, also observed during the 1918 influenza pandemic. Pre-existing H1N1 antibodies were not cross-reactive with the prior seasonal vaccine, forcing influenza experts to scramble to develop a new vaccine specific for the pandemic virus. We hypothesized that response to T-cell epitopes that are cross-conserved between pandemic H1N1 and the 2008 seasonal influenza vaccine strains might have contributed to partial protection from clinical illness among older adults, despite the lack of cross-reactive humoral immunity.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!